The Sjögren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death

Journal of Immunology

Volumn 176, Issue 10, 2006, Pages 6277-6285

  Espinosa, Alexander ^a   Zhou, Wei ^a   Ek, Monica ^a   Hedlund, Malin ^a   Brauner, Susanna ^a   Popovic, Karin ^a   Horvath, Linn ^a   Wallerskog, Therese ^a   Oukka, Mohamed ^b   Nyberg, Filippa ^a   Kuchroo, Vijay K ^b   Wahren Herlenius, Marie ^a,c  

^a DANDERYD HOSPITAL   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD40 ANTIGEN; RO52 ANTIGEN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; AUTOANTIBODY; RIBONUCLEOPROTEIN; SS A ANTIGEN; SS-A ANTIGEN; UBIQUITIN PROTEIN LIGASE;

ADULT; AGED; ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATIC DISEASE; SJOEGREN SYNDROME; STEADY STATE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UBIQUITINATION; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL LINE; ENZYMOLOGY; GENETICS; HELA CELL; IMMUNOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; HELA CELLS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME; UBIQUITIN-PROTEIN LIGASES;

EID: 33646466297     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.10.6277     Document Type: Article

References (46)

1. Jonsson, R., H. J. Haga, and T. Gordon. 2001. Sjögrens's Syndrome. Lippincott Williams & Wilkins, Philadelphia.
2. + T cells with lymphocyte activation and activity of disease in patients with primary Sjogren's syndrome. Arthritis Rheum. 42: 1673-1681.
3. Georgescu, L., R. K. Vakkalanka, K. B. Elkon, and M. K. Crow. 1997. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest. 100: 2622-2633.
4. Ren, Y., J. Tang, M. Y. Mok, A. W. Chan, A. Wu, and C. S. Lau. 2003. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 48: 2888-2897.
5. Emlen, W., J. Niebur, and R. Kadera. 1994. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152: 3685-3692.
6. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Ma. Rev. Immunol. 2: 965-975.
7. Bohnhorst, J. O., M. B. Bjorgan, J. E. Thoen, R. Jonsson, J. B. Natvig, and K. M. Thompson. 2002. Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin. Immunol. 103: 79-88.
8. Hansen, A., M. Odendahl, K. Reiter, A. M. Jacobi, E. Feist, J. Scholze, G. R. Burmester, P. E. Lipsky, and T. Dorner. 2002. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum. 46: 2160-2171.
9. Chan, E. K., J. C. Hamel, J. P. Buyon, and E. M. Tan. 1991. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J. Clin. Invest. 87: 68-76.
10. Wahren-Herlenius, M., S. Muller, and D. Isenberg. 1999. Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunol. Today 20: 234-240.
11. Salomonsson, S., T. Dorner, E. Theander, K. Bremme, P. Larsson, and M. Wahren-Herlenius. 2002. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum. 46: 1233-1241.
12. Salomonsson, S., S. E. Sonesson, L. Ottosson, S. Muhallab, T. Olsson, M. Sunnerhagen, V. K. Kuchroo, P. Thoren, E. Herlenius, and M. Wahren-Herlenius. 2005. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J. Exp. Med. 201: 11-17.
13. Reymond, A., G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, et al. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20: 2140-2151.
14. Ottosson, L., J. Hennig, A. Espinosa, S. Brauner, M. Wahren-Herlenius, and M. Sunnerhagen. 2005. Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome. Mol. Immunol.
15. 2+ dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52. J. Biol. Chem. 280: 33250-33261.
16. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70: 503-533.
17. Weissman, A. M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2: 169-178.
18. Vitali, C., S. Bombardieri, R. Jonsson, H. M. Moutsopoulos, E. L. Alexander, S. E. Carsons, T. E. Daniels, P. C. Fox, R. I. Fox, S. S. Kassan, et al. 2002. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61: 554-558.
19. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
20. Treier, M., L. M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain. Cell 78: 787-798.
21. Keech, C. L., T. P. Gordon, and J. McCluskey. 1996. Structural differences between the human and mouse 52-kD Ro autoantigens associated with poorly conserved autoantibody activity across species. Clin. Exp. Immunol. 104: 255-263.
22. Glimcher, L. H., K. J. Kim, I. Green, and W. E. Paul. 1982. Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J. Exp. Med. 155: 445-459.
23. Sambrook, J. R., and D. W. Russell. 2001. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
24. Heath, A. W., W. W. Wu, and M. C. Howard. 1994. Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24: 1828-1834.
25. Keech, C. L., T. P. Gordon, and J. McCluskey. 1995. Cytoplasmic accumulation of the 52 kDa Ro/SS-A nuclear autoantigen in transfected cell lines. J. Autoimmun. 8: 699-712.
26. Pruijn, G. J., F. H. Simons, and W. J. van Venrooij. 1997. Intracellular localization and nucleocytoplasmic transport of Ro RNP components. Eur. J. Cell Biol. 74: 123-132.
27. Pourmand, N., I. Blange, N. Ringertz, and I. Pettersson. 1998. Intracellular localisation of the Ro 52kD auto-antigen in HeLa cells visualised with green fluorescent protein chimeras. Autoimmunity 28: 225-233.
28. Dho, S. H., and K. S. Kwon. 2003. The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif. J. Biol. Chem. 278: 31902-31908.
29. Horn, E. J., A. Albor, Y. Liu, S. El-Hizawi, G. E. Vanderbeek, M. Babcock, G. T. Bowden, H. Hennings, G. Lozano, W. C. Weinberg, and M. Kulesz-Martin. 2004. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis 25: 157-167.
30. Joazeiro, C. A., S. S. Wing, H. Huang, J. D. Leverson, T. Hunter, and Y. C. Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286: 309-312.
31. Ruffner, H., C. A. Joazeiro, D. Hemmati, T. Hunter, and I. M. Verma. 2001. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. USA 98: 5134-5139.
32. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420: 25-27.
33. Zheng, N., P. Wang, P. D. Jeffrey, and N. P. Pavletich. 2000. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102: 533-539.
34. VanDemark, A. P., and C. P. Hill. 2002. Structural basis of ubiquitylation. Curr. Opin. Struct. Biol. 12: 822-830.
35. Borden, K. L., and P. S. Freemont. 1996. The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6: 395-401.
36. Rajendra, R., D. Malegaonkar, P. Pungaliya, H. Marshall, Z. Rasheed, J. Brownell, L. F. Liu, S. Lutzker, A. Saleem, and E. H. Rubin. 2004. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J. Biol. Chem. 279: 36440-36444.
37. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183: 159-167.
38. Fukuda-Kamitani, T., and T. Kamitani. 2002. Ubiquitination of Ro52 autoantigen. Biochem. Biophys. Res. Commun. 295: 774-778.
39. Di Donato, F., E. K. Chan, A. D. Askanase, M. Miranda-Carus, and J. P. Buyon. 2001. Interaction between 52 kDa SSA/Ro and deubiquitinating enzyme UnpEL: a clue to function. Int. J. Biochem. Cell Biol. 33: 924-934.
40. Fanelli, M., A. Fantozzi, P. De Luca, S. Caprodossi, S. Matsuzawa, M. A. Lazar, P. G. Pelicci, and S. Minucci. 2004. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome. J. Biol. Chem. 279: 5374-5379.
41. Plafker, S. M., K. S. Plafker, A. M. Weissman, and I. G. Macara. 2004. Ubiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear import. J. Cell Biol. 167: 649-659.
42. Zhao, B., and G. Bepler. 2001. Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer. Oncogene 20: 8154-8164.
43. Schiebe, M., P. Ohneseit, W. Hoffmann, R. Meyermann, H. P. Rodemann, and M. Bamberg. 2001. Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas. J. Cancer Res. Clin. Oncol. 127: 325-328.
44. Heath, A. W., R. Chang, N. Harada, L. Santos-Argumedo, J. Gordon, C. Hannum, D. Campbell, A. B. Shanafelt, E. A. Clark, R. Torres, et al. 1993. Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells. Cell Immunol. 152: 468-480.
45. Nyberg, F., J. Fransson, and E. Stephansson. 2000. Proliferation and effects of UVA irradiation in cultured fibroblasts from lesions in cutaneous lupus erythematosus. Exp. Dermatol. 9: 53-57.
46. Baima, B., and M. Sticherling. 2001. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br. J. Dermatol. 958-966.